ClinConnect ClinConnect Logo
Search / Trial NCT06263439

Surveillance of HFMD in Pediatric Outpatients

Launched by UNIVERSITY HOSPITAL, CLERMONT-FERRAND · Feb 15, 2024

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

Hand, Foot And Mouth Disease Enterovirus A71 Coxsackievirus A6 Herpangina Primary Care In Paediatrics

ClinConnect Summary

This clinical trial, titled "Surveillance of HFMD in Pediatric Outpatients," is focused on understanding the different types of viruses that cause Hand, Foot, and Mouth Disease (HFMD) and herpangina in children. Researchers want to find out if there are any new or unusual strains of these viruses and how they affect children differently. By studying this, they hope to catch any outbreaks early and learn more about how these infections behave.

The study is currently looking for children aged 0 to 10 years who have been diagnosed with HFMD or herpangina. Parents or guardians will need to agree to let their child participate, and children older than 3 years must also consent. If your child joins the trial, they will undergo some tests to help researchers gather important information about these diseases. Participation can contribute to better understanding and treatment of these common childhood illnesses.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Children aged 0 to 10 years presenting with HFMD or herpangina
  • Exclusion Criteria:
  • Refusal to participate by holders of parental authority
  • Refusal to participate for children over 3 years of age

About University Hospital, Clermont Ferrand

The University Hospital of Clermont-Ferrand is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its multidisciplinary approach, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes collaboration among healthcare professionals, researchers, and academic partners. With a strong commitment to improving patient outcomes, the institution actively engages in a wide array of clinical studies, ranging from early-phase trials to large-scale interventions, aimed at addressing critical health challenges and enhancing treatment modalities. Its state-of-the-art facilities and expertise make it a pivotal contributor to clinical research in the region and beyond.

Locations

Clermont Ferrand, , France

Patients applied

0 patients applied

Trial Officials

Audrey MIRAND

Principal Investigator

University Hospital, Clermont-Ferrand

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported